A federal judge has dealt a major setback to the "indirect purchaser" plaintiffs in the massive antitrust litigation over the marketing of Wellbutrin XL, a popular antidepressant drug, by tossing out most of the claims on standing grounds. The plaintiffs, a group of employee benefit plans, were aiming to pursue the case as a class action, but U.S. District Judge Mary A. McLaughlin ruled they are entitled to pursue antitrust claims in only four states and consumer protection claims under the laws of two states.
August 07, 2009 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A federal judge has dealt a major setback to the “indirect purchaser” plaintiffs in the massive antitrust litigation over the marketing of Wellbutrin XL, a popular anti-depressant drug, by tossing out most of the claims on standing grounds.
The plaintiffs, a group of employee benefit plans, were aiming to pursue the case as a class action alleging claims under the consumer protection laws of 41 states and the antitrust laws of 23 states.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
